外显子组测序在人类疾病中的应用
|
摘要
据估计,约85%的人类遗传变异集中在蛋白编码区,因此对全部的蛋白编码区(外显子组)进行重测序,可以快速、有效地鉴定人类疾病遗传变异。以往鉴定孟德尔遗传病的致病基因多采用连锁分析结合候选定位克隆的方法,不仅耗时长,而且成功率低。2009年,科学家第一次应用外显子组测序在4名弗里曼谢尔登综合征(常染色体显性遗传病)中发现了位于MYH3中的点突变,显示出外显子组测序在孟德尔遗传病致病基因鉴定中的强大功效。就复杂疾病而言,传统的关联研究,包括全基因组关联研究(GWAS),虽然鉴定了大量的常见变异,但对低频变异和罕见变异的检测能力十分有限;深度测序的发展为解决上述问题提供了良好的契机。文章就外显子组测序在人类疾病中的应用进行了综述。
It is estimated that approximately 85% of human disease mutations are located in protein coding regions, and therefore selectively sequencing all protein coding regions(exome) would be cost-effective and an alternative strategy to identify variants of disease. Linkage analysis followed by candidate positional cloning has been used for identifying disease-causing genes of Mendelian disorders for a long time; however, this approach showed not only time-consuming but also low success rate. In 2009, scientists successfully identified one missense mutation in MYH3 among four individuals with Freeman Sheldon syndrome(one autosomal dominant disease) through exome sequencing, suggesting that exome sequencing could be a powerful tool for the identification of Mendelian disease variants. As for complex diseases, though traditional association studies and genome-wide association studies(GWAS) have identified a large number of common variants, their application in identification of low-frequency or rare variants is quite limited. The development of the next-generation sequencing technology provides us an opportunity to deal with the problem. In this review, we summarize the application of exome sequencing in human diseases.
It is estimated that approximately 85% of human disease mutations are located in protein coding regions, and therefore selectively sequencing all protein coding regions(exome) would be cost-effective and an alternative strategy to identify variants of disease. Linkage analysis followed by candidate positional cloning has been used for identifying disease-causing genes of Mendelian disorders for a long time; however, this approach showed not only time-consuming but also low success rate. In 2009, scientists successfully identified one missense mutation in MYH3 among four individuals with Freeman Sheldon syndrome(one autosomal dominant disease) through exome sequencing, suggesting that exome sequencing could be a powerful tool for the identification of Mendelian disease variants. As for complex diseases, though traditional association studies and genome-wide association studies(GWAS) have identified a large number of common variants, their application in identification of low-frequency or rare variants is quite limited. The development of the next-generation sequencing technology provides us an opportunity to deal with the problem. In this review, we summarize the application of exome sequencing in human diseases.
引文
[1]Mc Carthy MI,Abecasis GR,Cardon LR,Goldstein DB,Little J,Ioannidis JP,Hirschhorn JN.Genome-wide association studies for complex traits:consensus,uncertainty and challenges.Nat Rev Genet,2008,9(5):356–369.
[2]Mc Kusick VA.Mendelian Inheritance in Man and its online version,OMIM.Am J Hum Genet,2007,80(4):588–604.
[3]Antonarakis SE,Beckmann JS.Mendelian disorders deserve more attention.Nat Rev Genet,2006,7(4):277–282.
[4]Wang Y,Hu Y,Fang Y,Zhang KR,Yang H,Ma JT,Xu Q,Shen Y.Evidence of epistasis between the catechol-O-methyltransferase and aldehyde dehydrogenase3B1 genes in paranoid schizophrenia.Biol Psychiatry,2009,65(12):1048–1054.
[5]Xu Q,Jia YB,Zhang BY,Zou K,Tao YB,Wang YP,Qiang BQ,Wu GY,Shen Y,Ji HK,Huang Y,Sun XQ,Ji L,Li YD,Yuan YB,Shu L,Yu X,Shen YC,Yu YQ,Ju GZ,Chinese Schizophrenia Consortium.Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia:a novel strategy for complex disorders.Mol Psychiatry,2004,9(5):510–521.
[6]Pharoah PD,Tsai YY,Ramus SJ,Phelan CM,Goode EL,Lawrenson K,Buckley M,Fridley BL,Tyrer JP,Shen H,Weber R,Karevan R,Larson MC,Song H,Tessier DC,Bacot F,Vincent D,Cunningham JM,Dennis J,Dicks E,Aben KK,Anton-Culver H,Antonenkova N,Armasu SM,Baglietto L,Bandera EV,Beckmann MW,Birrer MJ,Bloom G,Bogdanova N,Brenton JD,Brinton LA,Brooks-Wilson A,Brown R,Butzow R,Campbell I,Carney ME,Carvalho RS,Chang-Claude J,Chen YA,Chen Z,Chow WH,Cicek MS,Coetzee G,Cook LS,Cramer DW,Cybulski C,Dansonka-Mieszkowska A,Despierre E,Doherty JA,Drk T,du Bois A,Dürst M,Eccles D,Edwards R,Ekici AB,Fasching PA,Fenstermacher D,Flanagan J,Gao YT,Garcia-Closas M,Gentry-Maharaj A,Giles G,Gjyshi A,Gore M,Gronwald J,Guo Q,Halle MK,Harter P,Hein A,Heitz F,Hillemanns P,Hoatlin M,Hgdall E,Hgdall CK,Hosono S,Jakubowska A,Jensen A,Kalli KR,Karlan BY,Kelemen LE,Kiemeney LA,Kjaer SK,Konecny GE,Krakstad C,Kupryjanczyk J,Lambrechts D,Lambrechts S,Le ND,Lee N,Lee J,Leminen A,Lim BK,Lissowska J,Lubiński J,Lundvall L,Lurie G,Massuger LF,Matsuo K,Mc Guire V,Mc Laughlin JR,Menon U,Modugno F,Moysich KB,Nakanishi T,Narod SA,Ness RB,Nevanlinna H,Nickels S,Noushmehr H,Odunsi K,Olson S,Orlow I,Paul J,Pejovic T,Pelttari LM,Permuth-Wey J,Pike MC,Poole EM,Qu X,Risch HA,Rodriguez-Rodriguez L,Rossing MA,Rudolph A,Runnebaum I,Rzepecka IK,Salvesen HB,Schwaab I,Severi G,Shen H,Shridhar V,Shu XO,Sieh W,Southey MC,Spellman P,Tajima K,Teo SH,Terry KL,Thompson PJ,Timorek A,Tworoger SS,van Altena AM,van den Berg D,Vergote I,Vierkant RA,Vitonis AF,Wang-Gohrke S,Wentzensen N,Whittemore AS,Wik E,Winterhoff B,Woo YL,Wu AH,Yang HP,Zheng W,Ziogas A,Zulkifli F,Goodman MT,Hall P,Easton DF,Pearce CL,Berchuck A,Chenevix-Trench G,Iversen E,Monteiro AN,Gayther SA,Schildkraut JM,Sellers TA.GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.Nat Genet,2013,45(4):362–370,370e1–370e2.
[7]Schork NJ,Murray SS,Frazer KA,Topol EJ.Common vs.rare allele hypotheses for complex diseases.Curr Opin Genet Dev,2009,19(3):212–219.
[8]Manolio TA,Collins FS,Cox NJ,Goldstein DB,Hindorff LA,Hunter DJ,Mc Carthy MI,Ramos EM,Cardon LR,Chakravarti A,Cho JH,Guttmacher AE,Kong A,Kruglyak L,Mardis E,Rotimi CN,Slatkin M,Valle D,Whittemore AS,Boehnke M,Clark AG,Eichler EE,Gibson G,Haines JL,Mackay TF,Mc Carroll SA,Visscher PM.Finding the missing heritability of complex diseases.Nature,2009,461(7265):747–753.
[9]Witte JS.Rare genetic variants and treatment response:sample size and analysis issues.Stat Med,2012,31(25):3041–3050.
[10]Metzker ML.Sequencing technologies-the next generation.Nat Rev Genet,2010,11(1):31–46.
[11]Choi M,Scholl UI,Ji W,Liu T,Tikhonova IR,Zumbo P,Nayir A,Bakkalolu A,zen S,Sanjad S,Nelson-Williams C,Farhi A,Mane S,Lifton RP.Genetic diagnosis by whole exome capture and massively parallel DNA sequencing.Proc Natl Acad Sci U S A,2009,106(45):19096–19101.
[12]Jordan CT,Cao L,Roberson ED,Pierson KC,Yang CF,Joyce CE,Ryan C,Duan SH,Helms CA,Liu Y,Chen YQ,Mc Bride AA,Hwu WL,Wu JY,Chen YT,Menter A,Goldbach-Mansky R,Lowes MA,Bowcock AM.PSORS2is due to mutations in CARD14.Am J Hum Genet,2012,90(5):784–795.
[13]Li JY,Zhu XL,Wang X,Sun W,Feng B,Du T,Sun B,Niu FH,Wei H,Wu XP,Dong L,Li LP,Cai XQ,Wang YP,Liu Y.Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis.J Med Genet,2012,49(2):76–78.
[14]Ng SB,Turner EH,Robertson PD,Flygare SD,Bigham AW,Lee C,Shaffer T,Wong M,Bhattacharjee A,Eichler EE,Bamshad M,Nickerson DA,Shendure J.Targeted capture and massively parallel sequencing of 12human exomes.Nature,2009,461(7261):272–276.
[15]Mardis ER.Next-generation DNA sequencing methods.Annu Rev Genomics Hum Genet,2008,9:387–402.
[16]Shendure J,Ji H.Next-generation DNA sequencing.Nat Biotechnol,2008,26(10):1135–1145.
[17]Millat G,Chanavat V,Rousson R.Evaluation of a new NGS method based on a custom Ampli Seq library and Ion Torrent PGM sequencing for the fast detection of genetic variations in cardiomyopathies.Clin Chim Acta,2014,433:266–271.
[18]Tsongalis GJ,Peterson JD,de Abreu FB,Tunkey CD,Gallagher TL,Strausbaugh LD,Wells WA,Amos CI.Routine use of the Ion Torrent Ampli SeqTM Cancer Hotspot Panel for identification of clinically actionable somatic mutations.Clin Chem Lab Med,2014,52(5):707–714.
[19]Niedringhaus TP,Milanova D,Kerby MB,Snyder MP,Barron AE.Landscape of next-generation sequencing technologies.Anal Chem,2011,83(12):4327–4341.
[20]Roberts RJ,Carneiro MO,Schatz MC.The advantages of SMRT sequencing.Genome Biol,2013,14(7):405.
[21]Li WK,Li FY,Zhang SY,Cai B,Zheng N,Nie Y,Zhou D,Zhao Q.Automatic analysis pipeline of next-generation sequencing data.Hereditas,2014,36(6):618–624.
[22]Ng SB,Buckingham KJ,Lee C,Bigham AW,Tabor HK,Dent KM,Huff CD,Shannon PT,Jabs EW,Nickerson DA,Shendure J,Bamshad MJ.Exome sequencing identifies the cause of a mendelian disorder.Nat Genet,2010,42(1):30–35.
[23]Zhang XJ.Exome sequencing greatly expedites the progressive research of Mendelian diseases.Front Med,2014,8(1):42–57.
[24]Boycott KM,Vanstone MR,Bulman DE,Mac Kenzie AE.Rare-disease genetics in the era of next-generation sequencing:discovery to translation.Nat Rev Genet,2013,14(10):681–691.
[25]Clayton-Smith J,O'Sullivan J,Daly S,Bhaskar S,Day R,Anderson B,Voss AK,Thomas T,Biesecker LG,Smith P,Fryer A,Chandler KE,Kerr B,Tassabehji M,Lynch SA,Krajewska-Walasek M,Mc Kee S,Smith J,Sweeney E,Mansour S,Mohammed S,Donnai D,Black G.Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome.Am J Hum Genet,2011,89(5):675–681.
[26]Chen WJ,Lin Y,Xiong ZQ,Wei W,Ni W,Tan GH,Guo SL,He J,Chen YF,Zhang QJ,Li HF,Lin Y,Murong SX,Xu JF,Wang N,Wu ZY.Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia.Nat Genet,2011,43(12):1252–1255.
[27]Hoischen A,van Bon BW,Rodríguez-Santiago B,Gi-lissen C,Vissers LE,de Vries P,Janssen I,van Lier B,Hastings R,Smithson SF,Newbury-Ecob R,Kjaergaard S,Goodship J,Mc Gowan R,Bartholdi D,Rauch A,Peippo M,Cobben JM,Wieczorek D,Gillessen-Kaesbach G,Veltman JA,Brunner HG,de Vries BB.De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome.Nat Genet,2011,43(8):729–731.
[28]Min BJ,Kim N,Chung T,Kim OH,Nishimura G,Chung CY,Song HR,Kim HW,Lee HR,Kim J,Kang TH,Seo ME,Yang SD,Kim DH,Lee SB,Kim JI,Seo JS,Choi JY,Kang D,Kim D,Park WY,Cho TJ.Whole-exome sequencing identifies mutations of KIF22 in spondyloepimetaphyseal dysplasia with joint laxity,leptodactylic type.Am J Hum Genet,2011,89(6):760–766.
[29]Marduel M,Ouguerram K,Serre V,Bonnefont-Rousselot D,Marques-Pinheiro A,Erik BK,Devillers M,Luc G,Lecerf JM,Tosolini L,Erlich D,Peloso GM,Stitziel N,NitchkéP,Jas JP,French Research Network on ADH,Abifadel M,Kathiresan S,Leren TP,Rabes JP,Boileau C,Varret M.Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation.Hum Mutat,2013,34(1):83–87.
[30]Zeitz C,Jacobson SG,Hamel CP,Bujakowska K,Neuille M,Orhan E,Zanlonghi X,Lancelot ME,Michiels C,Schwartz SB,Bocquet B,Congenital Stationary Night Blindness Consortium,Antonio A,Audier C,Letexier M,Saraiva JP,Luu TD,Sennlaub F,Nguyen H,Poch O,Dollfus H,Lecompte O,Kohl S,Sahel JA,Bhattacharya SS,Audo I.Whole-exome sequencing identifies LRIT3mutations as a cause of autosomal-recessive complete congenital stationary night blindness.Am J Hum Genet,2013,92(1):67–75.
[31]Perrault I,Hamdan FF,Rio M,Capo-Chichi JM,Boddaert N,Décarie JC,Maranda B,Nabbout R,Sylvain M,Lortie A,Roux PP,Rossignol E,Gérard X,Barcia G,Berquin P,Munnich A,Rouleau GA,Kaplan J,Rozet JM,Michaud JL.Mutations in DOCK7 in Individuals with Epileptic Encephalopathy and Cortical Blindness.Am J Hum Genet,2014,94(6):891–897.
[32]Staropoli JF,Karaa A,Lim ET,Kirby A,Elbalalesy N,Romansky SG,Leydiker KB,Coppel SH,Barone R,Xin W,Mac Donald ME,Abdenur JE,Daly MJ,Sims KB,Cotman SL.A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.Am J Hum Genet,2012,91(1):202–208.
[33]De Stefano GM,Kurban M,Anyane-Yeboa K,Dall'Armi C,Di Paolo G,Feenstra H,Silverberg N,Rohena L,López-Cepeda LD,Jobanputra V,Fantauzzo KA,Kiuru M,Tadin-Strapps M,Sobrino A,Vitebsky A,Warburton D,Levy B,Salas-Alanis JC,Christiano AM.Mutations in the cholesterol transporter gene ABCA5 are associated with excessive hair overgrowth.PLo S Genet,2014,10(5):e1004333.
[34]Sankaran VG,Ghazvinian R,Do R,Thiru P,Vergilio JA,Beggs AH,Sieff CA,Orkin SH,Nathan DG,Lander ES,Gazda HT.Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia.J Clin Invest,2012,122(7):2439–2443.
[35]Zanni G,CalìT,Kalscheuer VM,Ottolini D,Barresi S,Lebrun N,Montecchi-Palazzi L,Hu H,Chelly J,Bertini E,Brini M,Carafoli E.Mutation of plasma membrane Ca2+ATPase isoform 3 in a family with X-linked congenital cerebellar ataxia impairs Ca2+homeostasis.Proc Natl Acad Sci U S A,2012,109(36):14514–14519.
[36]Zhang XY,Wen JM,Yang W,Wang C,Gao LN,Zheng LH,Wang T,Ran KK,Li YL,Li XY,Xu M,Luo JY,Feng SL,Ma XX,Ma HY,Chai ZY,Zhou Z,Yao J,Zhang X,Liu JY.Gain-of-function mutations in SCN11A cause familial episodic pain.Am J Hum Genet,2013,93(5):957–966.
[37]Welter D,Mac Arthur J,Morales J,Burdett T,Hall P,Junkins H,Klemm A,Flicek P,Manolio T,Hindorff L,Parkinson H.The NHGRI GWAS Catalog,a curated resource of SNP-trait associations.Nucleic Acids Res,2014,42(Database issue):D1001–D1006.
[38]Cirulli ET,Goldstein DB.Uncovering the roles of rare variants in common disease through whole-genome sequencing.Nat Rev Genet,2010,11(6):415–425.
[39]Maher B.Personal genomes:The case of the missing heritability.Nature,2008,456(7218):18–21.
[40]Dickson SP,Wang K,Krantz I,Hakonarson H,Goldstein DB.Rare variants create synthetic genome-wide associations.PLo S Biol,2010,8(1):e1000294.
[41]Sebat J,Lakshmi B,Malhotra D,Troge J,Lese-Martin C,Walsh T,Yamrom B,Yoon S,Krasnitz A,Kendall J,Leotta A,Pai D,Zhang R,Lee YH,Hicks J,Spence SJ,Lee AT,Puura K,Lehtimaki T,Ledbetter D,Gregersen PK,Bregman J,Sutcliffe JS,Jobanputra V,Chung W,Warburton D,King MC,Skuse D,Geschwind DH,Gilliam TC,Ye K,Wigler M.Strong association of de novo copy number mutations with autism.Science,2007,316(5823):445–449.
[42]Chang H,Jackson DG,Kayne PS,Ross-Macdonald PB,Ryseck RP,Siemers NO.Exome sequencing reveals com-prehensive genomic alterations across eight cancer cell lines.PLo S ONE,2011,6(6):e21097.
[43]Brastianos PK,Taylor-Weiner A,Manley PE,Jones RT,Dias-Santagata D,Thorner AR,Lawrence MS,Rodriguez FJ,Bernardo LA,Schubert L,Sunkavalli A,Shillingford N,Calicchio ML,Lidov HG,Taha H,Martinez-Lage M,Santi M,Storm PB,Lee JY,Palmer JN,Adappa ND,Scott RM,Dunn IF,Laws EJ,Stewart C,Ligon KL,Hoang MP,Van Hummelen P,Hahn WC,Louis DN,Resnick AC,Kieran MW,Getz G,Santagata S.Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.Nat Genet,2014,46(2):161–165.
[44]Li ML,Zhang Z,Li XG,Ye JY,Wu XS,Tan ZJ,Liu C,Shen BY,Wang XA,Wu WG,Zhou DZ,Zhang D,Wang T,Liu BY,Qu K,Ding QC,Weng H,Ding Q,Mu JS,Shu YJ,Bao RF,Cao Y,Chen PZ,Liu TY,Jiang L,Hu YP,Dong P,Gu J,Lu W,Shi WB,Lu JH,Gong W,Tang ZH,Zhang Y,Wang XF,Chin YE,Weng XL,Zhang H,Tang W,Zheng YL,He L,Wang H,Liu Y,Liu YB.Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the Erb B pathway.Nat Genet,2014,46(8):872–876.
[45]Kakiuchi M,Nishizawa T,Ueda H,Gotoh K,Tanaka A,Hayashi A,Yamamoto S,Tatsuno K,Katoh H,Watanabe Y,Ichimura T,Ushiku T,Funahashi S,Tateishi K,Wada I,Shimizu N,Nomura S,Koike K,Seto Y,Fukayama M,Aburatani H,Ishikawa S.Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.Nat Genet,2014,46(6):583–587.
[46]Xu B,Roos JL,Dexheimer P,Boone B,Plummer B,Levy S,Gogos JA,Karayiorgou M.Exome sequencing supports a de novo mutational paradigm for schizophrenia.Nat Genet,2011,43(9):864–868.
[47]Xu B,Roos JL,Levy S,van Rensburg EJ,Gogos JA,Karayiorgou M.Strong association of de novo copy number mutations with sporadic schizophrenia.Nat Genet,2008,40(7):880–885.
[48]Takata A,Xu B,Ionita-Laza I,Roos JL,Gogos JA,Karayiorgou M.Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene.Neuron,2014,82(4):773–780.
[49]Gregor A,Oti M,Kouwenhoven EN,Hoyer J,Sticht H,Ekici AB,Kjaergaard S,Rauch A,Stunnenberg HG,Uebe S,Vasileiou G,Reis A,Zhou HQ,Zweier C.De novo mutations in the genome organizer CTCF cause intellectual disability.Am J Hum Genet,2013,93(1):124–131.
[50]Tavassoli T,Kolevzon A,Wang AT,Curchack-Lichtin J,Halpern D,Schwartz L,Soffes S,Bush L,Grodberg D,Cai G,Buxbaum JD.De novo SCN2A splice site mutation in a boy with Autism spectrum disorder.BMC Med Genet,2014,15:35.
[51]Schaffer AE,Eggens VR,Caglayan AO,Reuter MS,Scott E,Coufal NG,Silhavy JL,Xue YC,Kayserili H,Yasuno K,Rosti RO,Abdellateef M,Caglar C,Kasher PR,Cazemier JL,Weterman MA,Cantagrel V,Cai N,Zweier C,Altunoglu U,Satkin NB,Aktar F,Tuysuz B,Yalcinkaya C,Caksen H,Bilguvar K,Fu XD,Trotta CR,Gabriel S,Reis A,Gunel M,Baas F,Gleeson JG.CLP1 founder mutation links t RNA splicing and maturation to cerebellar development and neurodegeneration.Cell,2014,157(3):651–663.
[52]Karaca E,Weitzer S,Pehlivan D,Shiraishi H,Gogakos T,Hanada T,Jhangiani SN,Wiszniewski W,Withers M,Campbell IM,Erdin S,Isikay S,Franco LM,Gonzaga-Jauregui C,Gambin T,Gelowani V,Hunter JV,Yesil G,Koparir E,Yilmaz S,Brown M,Briskin D,Hafner M,Morozov P,Farazi TA,Bernreuther C,Glatzel M,Trattnig S,Friske J,Kronnerwetter C,Bainbridge MN,Gezdirici A,Seven M,Muzny DM,Boerwinkle E,Ozen M,Clausen T,Tuschl T,Yuksel A,Hess A,Gibbs RA,Martinez J,Penninger JM,Lupski JR.Human CLP1 mutations alter t RNA biogenesis,affecting both peripheral and central nervous system function.Cell,2014,157(3):636–650.
[53]Glessner J,Bick AG,Ito K,Homsy J,Rodriguez-Murillo L,Fromer M,Mazaika EJ,Vardarajan B,Italia MJ,Leipzig J,De Palma S,Golhar R,Sanders SJ,Yamrom B,Ronemus M,Iossifov I,Willsey AJ,State MW,Kaltman JR,White PS,Shen Y,Warburton D,Brueckner M,Seidman C,Goldmuntz E,Gelb BD,Lifton R,Seidman JG,Hakonarson H,Chung WK.Increased frequency of de novo copy number variations in congenital heart disease by integrative analysis of SNP array and exome sequence data.Circ Res,2014:CIRCRESAHA.114.304458.
[54]Theis JL,Sharpe KM,Matsumoto ME,Chai HS,Nair AA,Theis JD,de Andrade M,Wieben ED,Michels VV,Olson TM.Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy.Circ Cardiovasc Genet,2011,4(6):585–594.
[55]Musunuru K,Pirruccello JP,Do R,Peloso GM,Guiducci C,Sougnez C,Garimella KV,Fisher S,Abreu J,Barry AJ,Fennell T,Banks E,Ambrogio L,Cibulskis K,Kernytsky A,Gonzalez E,Rudzicz N,Engert JC,De Pristo MA,Daly MJ,Cohen JC,Hobbs HH,Altshuler D,Schonfeld G,Gabriel SB,Yue P,Kathiresan S.Exome sequencing,ANGPTL3 mutations,and familial combined hypolipidemia.N Engl J Med,2010,363(23):2220–2227.
[56]Rios J,Stein E,Shendure J,Hobbs HH,Cohen JC.Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia.Hum Mol Genet,2010,19(22):4313–4318.
[57]Lange LA,Hu YN,Zhang H,Xue CY,Schmidt EM,Tang ZZ,Bizon C,Lange EM,Smith JD,Turner EH,Jun G,Kang HM,Peloso G,Auer P,Li KP,Flannick J,Zhang J,Fuchsberger C,Gaulton K,Lindgren C,Locke A,Manning A,Sim XL,Rivas MA,Holmen OL,Gottesman O,Lu YC,Ruderfer D,Stahl EA,Duan Q,Li Y,Durda P,Jiao S,Isaacs A,Hofman A,Bis JC,Correa A,Griswold ME,Jakobsdottir J,Smith AV,Schreiner PJ,Feitosa MF,Zhang Q,Huffman JE,Crosby J,Wassel CL,Do R,Franceschini N,Martin LW,Robinson JG,Assimes TL,Crosslin DR,Rosenthal EA,Tsai M,Rieder MJ,Farlow DN,Folsom AR,Lumley T,Fox ER,Carlson CS,Peters U,Jackson RD,van Duijn CM,Uitterlinden AG,Levy D,Rotter JI,Taylor HA,Gudnason VJ,Siscovick DS,Fornage M,Borecki IB,Hayward C,Rudan I,Chen YE,Bottinger EP,Loos RJ,Saetrom P,Hveem K,Boehnke M,Groop L,Mc Carthy M,Meitinger T,Ballantyne CM,Gabriel SB,O'Donnell CJ,Post WS,North KE,Reiner AP,Boerwinkle E,Psaty BM,Altshuler D,Kathiresan S,Lin DY,Jarvik GP,Cupples LA,Kooperberg C,Wilson JG,Nickerson DA,Abecasis GR,Rich SS,Tracy RP,Willer CJ.Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.Am J Hum Genet,2014,94(2):233–245.
[58]Kim DS,Crosslin DR,Auer PL,Suzuki SM,Marsillach J,Burt AA,Gordon AS,Meschia JF,Nalls MA,Worrall BB,Longstreth WJ Jr,Gottesman RF,Furlong CE,Peters U,Rich SS,Nickerson DA,Jarvik GP.Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project[S].J Lipid Res,2014,55(6):1173–1178.
[59]Yang YP,Muzny DM,Reid JG,Bainbridge MN,Willis A,Ward PA,Braxton A,Beuten J,Xia F,Niu ZY,Hardison M,Person R,Bekheirnia MR,Leduc MS,Kirby A,Pham P,Scull J,Wang M,Ding Y,Plon SE,Lupski JR,Beaudet AL,Gibbs RA,Eng CM.Clinical whole-exome sequencing for the diagnosis of mendelian disorders.N Engl J Med,2013,369(16):1502–1511.
[60]Mac Arthur DG,Manolio TA,Dimmock DP,Rehm HL,Shendure J,Abecasis GR,Adams DR,Altman RB,Antonarakis SE,Ashley EA,Barrett JC,Biesecker LG,Conrad DF,Cooper GM,Cox NJ,Daly MJ,Gerstein MB,Goldstein DB,Hirschhorn JN,Leal SM,Pennacchio LA,Stamatoyannopoulos JA,Sunyaev SR,Valle D,Voight BF,Winckler W,Gunter C.Guidelines for investigating causality of sequence variants in human disease.Nature,2014,508(7497):469–476.
[61]Biesecker LG,Green RC.Diagnostic clinical genome and exome sequencing.N Engl J Med,2014,370(25):2418–2425.
[62]Stenson PD,Ball EV,Mort M,Phillips AD,Shiel JA,Thomas NS,Abeysinghe S,Krawczak M,Cooper DN.Human Gene Mutation Database(HGMD):2003 update.Hum Mutat,2003,21(6):577–581.
[63]Gilissen C,Hoischen A,Brunner HG,Veltman JA.Disease gene identification strategies for exome sequencing.Eur J Hum Genet,2012,20(5):490–497.
[64]Quail MA,Smith M,Coupland P,Otto TD,Harris SR,Connor TR,Bertoni A,Swerdlow HP,Gu Y.A tale of three next generation sequencing platforms:comparison of Ion Torrent,Pacific Biosciences and Illumina Mi Seq sequencers.BMC Genomics,2012,13:341.
[65]Hoischen A,Gilissen C,Arts P,Wieskamp N,van der Vliet W,Vermeer S,Steehouwer M,de Vries P,Meijer R,Seiqueros J,Knoers NVAM,Buckley MF,Scheffer H,Veltman JA.Massively parallel sequencing of ataxia genes after array-based enrichment.Hum Mutat,2010,31(4):494–499.
[66]Yang X,Chockalingam SP,Aluru S.A survey of error-correction methods for next-generation sequencing.Brief Bioinform,2013,14(1):56–66.
[67]Schmitt MW,Kennedy SR,Salk JJ,Fox EJ,Hiatt JB,Loeb LA.Detection of ultra-rare mutations by next-generation sequencing.Proc Natl Acad Sci U S A,2012,109(36):14508–14513.
[68]Quail MA,Smith M,Coupland P,Otto TD,Harris SR,Connor TR,Bertoni A,Swerdlow HP,Gu Y.A tale of three next generation sequencing platforms:comparison of Ion Torrent,Pacific Biosciences and Illumina Mi Seq sequencers.BMC Genomics,2012,13:341.
[69]Robasky K,Lewis NE,Church GM.The role of replicates for error mitigation in next-generation sequencing.Nat Rev Genet,2014,15(1):56–62.
[70]张鑫,李敏,张学军.全基因组外显子测序及其应用.遗传,2011,33(8):847–856.
[2]Mc Kusick VA.Mendelian Inheritance in Man and its online version,OMIM.Am J Hum Genet,2007,80(4):588–604.
[3]Antonarakis SE,Beckmann JS.Mendelian disorders deserve more attention.Nat Rev Genet,2006,7(4):277–282.
[4]Wang Y,Hu Y,Fang Y,Zhang KR,Yang H,Ma JT,Xu Q,Shen Y.Evidence of epistasis between the catechol-O-methyltransferase and aldehyde dehydrogenase3B1 genes in paranoid schizophrenia.Biol Psychiatry,2009,65(12):1048–1054.
[5]Xu Q,Jia YB,Zhang BY,Zou K,Tao YB,Wang YP,Qiang BQ,Wu GY,Shen Y,Ji HK,Huang Y,Sun XQ,Ji L,Li YD,Yuan YB,Shu L,Yu X,Shen YC,Yu YQ,Ju GZ,Chinese Schizophrenia Consortium.Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia:a novel strategy for complex disorders.Mol Psychiatry,2004,9(5):510–521.
[6]Pharoah PD,Tsai YY,Ramus SJ,Phelan CM,Goode EL,Lawrenson K,Buckley M,Fridley BL,Tyrer JP,Shen H,Weber R,Karevan R,Larson MC,Song H,Tessier DC,Bacot F,Vincent D,Cunningham JM,Dennis J,Dicks E,Aben KK,Anton-Culver H,Antonenkova N,Armasu SM,Baglietto L,Bandera EV,Beckmann MW,Birrer MJ,Bloom G,Bogdanova N,Brenton JD,Brinton LA,Brooks-Wilson A,Brown R,Butzow R,Campbell I,Carney ME,Carvalho RS,Chang-Claude J,Chen YA,Chen Z,Chow WH,Cicek MS,Coetzee G,Cook LS,Cramer DW,Cybulski C,Dansonka-Mieszkowska A,Despierre E,Doherty JA,Drk T,du Bois A,Dürst M,Eccles D,Edwards R,Ekici AB,Fasching PA,Fenstermacher D,Flanagan J,Gao YT,Garcia-Closas M,Gentry-Maharaj A,Giles G,Gjyshi A,Gore M,Gronwald J,Guo Q,Halle MK,Harter P,Hein A,Heitz F,Hillemanns P,Hoatlin M,Hgdall E,Hgdall CK,Hosono S,Jakubowska A,Jensen A,Kalli KR,Karlan BY,Kelemen LE,Kiemeney LA,Kjaer SK,Konecny GE,Krakstad C,Kupryjanczyk J,Lambrechts D,Lambrechts S,Le ND,Lee N,Lee J,Leminen A,Lim BK,Lissowska J,Lubiński J,Lundvall L,Lurie G,Massuger LF,Matsuo K,Mc Guire V,Mc Laughlin JR,Menon U,Modugno F,Moysich KB,Nakanishi T,Narod SA,Ness RB,Nevanlinna H,Nickels S,Noushmehr H,Odunsi K,Olson S,Orlow I,Paul J,Pejovic T,Pelttari LM,Permuth-Wey J,Pike MC,Poole EM,Qu X,Risch HA,Rodriguez-Rodriguez L,Rossing MA,Rudolph A,Runnebaum I,Rzepecka IK,Salvesen HB,Schwaab I,Severi G,Shen H,Shridhar V,Shu XO,Sieh W,Southey MC,Spellman P,Tajima K,Teo SH,Terry KL,Thompson PJ,Timorek A,Tworoger SS,van Altena AM,van den Berg D,Vergote I,Vierkant RA,Vitonis AF,Wang-Gohrke S,Wentzensen N,Whittemore AS,Wik E,Winterhoff B,Woo YL,Wu AH,Yang HP,Zheng W,Ziogas A,Zulkifli F,Goodman MT,Hall P,Easton DF,Pearce CL,Berchuck A,Chenevix-Trench G,Iversen E,Monteiro AN,Gayther SA,Schildkraut JM,Sellers TA.GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.Nat Genet,2013,45(4):362–370,370e1–370e2.
[7]Schork NJ,Murray SS,Frazer KA,Topol EJ.Common vs.rare allele hypotheses for complex diseases.Curr Opin Genet Dev,2009,19(3):212–219.
[8]Manolio TA,Collins FS,Cox NJ,Goldstein DB,Hindorff LA,Hunter DJ,Mc Carthy MI,Ramos EM,Cardon LR,Chakravarti A,Cho JH,Guttmacher AE,Kong A,Kruglyak L,Mardis E,Rotimi CN,Slatkin M,Valle D,Whittemore AS,Boehnke M,Clark AG,Eichler EE,Gibson G,Haines JL,Mackay TF,Mc Carroll SA,Visscher PM.Finding the missing heritability of complex diseases.Nature,2009,461(7265):747–753.
[9]Witte JS.Rare genetic variants and treatment response:sample size and analysis issues.Stat Med,2012,31(25):3041–3050.
[10]Metzker ML.Sequencing technologies-the next generation.Nat Rev Genet,2010,11(1):31–46.
[11]Choi M,Scholl UI,Ji W,Liu T,Tikhonova IR,Zumbo P,Nayir A,Bakkalolu A,zen S,Sanjad S,Nelson-Williams C,Farhi A,Mane S,Lifton RP.Genetic diagnosis by whole exome capture and massively parallel DNA sequencing.Proc Natl Acad Sci U S A,2009,106(45):19096–19101.
[12]Jordan CT,Cao L,Roberson ED,Pierson KC,Yang CF,Joyce CE,Ryan C,Duan SH,Helms CA,Liu Y,Chen YQ,Mc Bride AA,Hwu WL,Wu JY,Chen YT,Menter A,Goldbach-Mansky R,Lowes MA,Bowcock AM.PSORS2is due to mutations in CARD14.Am J Hum Genet,2012,90(5):784–795.
[13]Li JY,Zhu XL,Wang X,Sun W,Feng B,Du T,Sun B,Niu FH,Wei H,Wu XP,Dong L,Li LP,Cai XQ,Wang YP,Liu Y.Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis.J Med Genet,2012,49(2):76–78.
[14]Ng SB,Turner EH,Robertson PD,Flygare SD,Bigham AW,Lee C,Shaffer T,Wong M,Bhattacharjee A,Eichler EE,Bamshad M,Nickerson DA,Shendure J.Targeted capture and massively parallel sequencing of 12human exomes.Nature,2009,461(7261):272–276.
[15]Mardis ER.Next-generation DNA sequencing methods.Annu Rev Genomics Hum Genet,2008,9:387–402.
[16]Shendure J,Ji H.Next-generation DNA sequencing.Nat Biotechnol,2008,26(10):1135–1145.
[17]Millat G,Chanavat V,Rousson R.Evaluation of a new NGS method based on a custom Ampli Seq library and Ion Torrent PGM sequencing for the fast detection of genetic variations in cardiomyopathies.Clin Chim Acta,2014,433:266–271.
[18]Tsongalis GJ,Peterson JD,de Abreu FB,Tunkey CD,Gallagher TL,Strausbaugh LD,Wells WA,Amos CI.Routine use of the Ion Torrent Ampli SeqTM Cancer Hotspot Panel for identification of clinically actionable somatic mutations.Clin Chem Lab Med,2014,52(5):707–714.
[19]Niedringhaus TP,Milanova D,Kerby MB,Snyder MP,Barron AE.Landscape of next-generation sequencing technologies.Anal Chem,2011,83(12):4327–4341.
[20]Roberts RJ,Carneiro MO,Schatz MC.The advantages of SMRT sequencing.Genome Biol,2013,14(7):405.
[21]Li WK,Li FY,Zhang SY,Cai B,Zheng N,Nie Y,Zhou D,Zhao Q.Automatic analysis pipeline of next-generation sequencing data.Hereditas,2014,36(6):618–624.
[22]Ng SB,Buckingham KJ,Lee C,Bigham AW,Tabor HK,Dent KM,Huff CD,Shannon PT,Jabs EW,Nickerson DA,Shendure J,Bamshad MJ.Exome sequencing identifies the cause of a mendelian disorder.Nat Genet,2010,42(1):30–35.
[23]Zhang XJ.Exome sequencing greatly expedites the progressive research of Mendelian diseases.Front Med,2014,8(1):42–57.
[24]Boycott KM,Vanstone MR,Bulman DE,Mac Kenzie AE.Rare-disease genetics in the era of next-generation sequencing:discovery to translation.Nat Rev Genet,2013,14(10):681–691.
[25]Clayton-Smith J,O'Sullivan J,Daly S,Bhaskar S,Day R,Anderson B,Voss AK,Thomas T,Biesecker LG,Smith P,Fryer A,Chandler KE,Kerr B,Tassabehji M,Lynch SA,Krajewska-Walasek M,Mc Kee S,Smith J,Sweeney E,Mansour S,Mohammed S,Donnai D,Black G.Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome.Am J Hum Genet,2011,89(5):675–681.
[26]Chen WJ,Lin Y,Xiong ZQ,Wei W,Ni W,Tan GH,Guo SL,He J,Chen YF,Zhang QJ,Li HF,Lin Y,Murong SX,Xu JF,Wang N,Wu ZY.Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia.Nat Genet,2011,43(12):1252–1255.
[27]Hoischen A,van Bon BW,Rodríguez-Santiago B,Gi-lissen C,Vissers LE,de Vries P,Janssen I,van Lier B,Hastings R,Smithson SF,Newbury-Ecob R,Kjaergaard S,Goodship J,Mc Gowan R,Bartholdi D,Rauch A,Peippo M,Cobben JM,Wieczorek D,Gillessen-Kaesbach G,Veltman JA,Brunner HG,de Vries BB.De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome.Nat Genet,2011,43(8):729–731.
[28]Min BJ,Kim N,Chung T,Kim OH,Nishimura G,Chung CY,Song HR,Kim HW,Lee HR,Kim J,Kang TH,Seo ME,Yang SD,Kim DH,Lee SB,Kim JI,Seo JS,Choi JY,Kang D,Kim D,Park WY,Cho TJ.Whole-exome sequencing identifies mutations of KIF22 in spondyloepimetaphyseal dysplasia with joint laxity,leptodactylic type.Am J Hum Genet,2011,89(6):760–766.
[29]Marduel M,Ouguerram K,Serre V,Bonnefont-Rousselot D,Marques-Pinheiro A,Erik BK,Devillers M,Luc G,Lecerf JM,Tosolini L,Erlich D,Peloso GM,Stitziel N,NitchkéP,Jas JP,French Research Network on ADH,Abifadel M,Kathiresan S,Leren TP,Rabes JP,Boileau C,Varret M.Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation.Hum Mutat,2013,34(1):83–87.
[30]Zeitz C,Jacobson SG,Hamel CP,Bujakowska K,Neuille M,Orhan E,Zanlonghi X,Lancelot ME,Michiels C,Schwartz SB,Bocquet B,Congenital Stationary Night Blindness Consortium,Antonio A,Audier C,Letexier M,Saraiva JP,Luu TD,Sennlaub F,Nguyen H,Poch O,Dollfus H,Lecompte O,Kohl S,Sahel JA,Bhattacharya SS,Audo I.Whole-exome sequencing identifies LRIT3mutations as a cause of autosomal-recessive complete congenital stationary night blindness.Am J Hum Genet,2013,92(1):67–75.
[31]Perrault I,Hamdan FF,Rio M,Capo-Chichi JM,Boddaert N,Décarie JC,Maranda B,Nabbout R,Sylvain M,Lortie A,Roux PP,Rossignol E,Gérard X,Barcia G,Berquin P,Munnich A,Rouleau GA,Kaplan J,Rozet JM,Michaud JL.Mutations in DOCK7 in Individuals with Epileptic Encephalopathy and Cortical Blindness.Am J Hum Genet,2014,94(6):891–897.
[32]Staropoli JF,Karaa A,Lim ET,Kirby A,Elbalalesy N,Romansky SG,Leydiker KB,Coppel SH,Barone R,Xin W,Mac Donald ME,Abdenur JE,Daly MJ,Sims KB,Cotman SL.A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.Am J Hum Genet,2012,91(1):202–208.
[33]De Stefano GM,Kurban M,Anyane-Yeboa K,Dall'Armi C,Di Paolo G,Feenstra H,Silverberg N,Rohena L,López-Cepeda LD,Jobanputra V,Fantauzzo KA,Kiuru M,Tadin-Strapps M,Sobrino A,Vitebsky A,Warburton D,Levy B,Salas-Alanis JC,Christiano AM.Mutations in the cholesterol transporter gene ABCA5 are associated with excessive hair overgrowth.PLo S Genet,2014,10(5):e1004333.
[34]Sankaran VG,Ghazvinian R,Do R,Thiru P,Vergilio JA,Beggs AH,Sieff CA,Orkin SH,Nathan DG,Lander ES,Gazda HT.Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia.J Clin Invest,2012,122(7):2439–2443.
[35]Zanni G,CalìT,Kalscheuer VM,Ottolini D,Barresi S,Lebrun N,Montecchi-Palazzi L,Hu H,Chelly J,Bertini E,Brini M,Carafoli E.Mutation of plasma membrane Ca2+ATPase isoform 3 in a family with X-linked congenital cerebellar ataxia impairs Ca2+homeostasis.Proc Natl Acad Sci U S A,2012,109(36):14514–14519.
[36]Zhang XY,Wen JM,Yang W,Wang C,Gao LN,Zheng LH,Wang T,Ran KK,Li YL,Li XY,Xu M,Luo JY,Feng SL,Ma XX,Ma HY,Chai ZY,Zhou Z,Yao J,Zhang X,Liu JY.Gain-of-function mutations in SCN11A cause familial episodic pain.Am J Hum Genet,2013,93(5):957–966.
[37]Welter D,Mac Arthur J,Morales J,Burdett T,Hall P,Junkins H,Klemm A,Flicek P,Manolio T,Hindorff L,Parkinson H.The NHGRI GWAS Catalog,a curated resource of SNP-trait associations.Nucleic Acids Res,2014,42(Database issue):D1001–D1006.
[38]Cirulli ET,Goldstein DB.Uncovering the roles of rare variants in common disease through whole-genome sequencing.Nat Rev Genet,2010,11(6):415–425.
[39]Maher B.Personal genomes:The case of the missing heritability.Nature,2008,456(7218):18–21.
[40]Dickson SP,Wang K,Krantz I,Hakonarson H,Goldstein DB.Rare variants create synthetic genome-wide associations.PLo S Biol,2010,8(1):e1000294.
[41]Sebat J,Lakshmi B,Malhotra D,Troge J,Lese-Martin C,Walsh T,Yamrom B,Yoon S,Krasnitz A,Kendall J,Leotta A,Pai D,Zhang R,Lee YH,Hicks J,Spence SJ,Lee AT,Puura K,Lehtimaki T,Ledbetter D,Gregersen PK,Bregman J,Sutcliffe JS,Jobanputra V,Chung W,Warburton D,King MC,Skuse D,Geschwind DH,Gilliam TC,Ye K,Wigler M.Strong association of de novo copy number mutations with autism.Science,2007,316(5823):445–449.
[42]Chang H,Jackson DG,Kayne PS,Ross-Macdonald PB,Ryseck RP,Siemers NO.Exome sequencing reveals com-prehensive genomic alterations across eight cancer cell lines.PLo S ONE,2011,6(6):e21097.
[43]Brastianos PK,Taylor-Weiner A,Manley PE,Jones RT,Dias-Santagata D,Thorner AR,Lawrence MS,Rodriguez FJ,Bernardo LA,Schubert L,Sunkavalli A,Shillingford N,Calicchio ML,Lidov HG,Taha H,Martinez-Lage M,Santi M,Storm PB,Lee JY,Palmer JN,Adappa ND,Scott RM,Dunn IF,Laws EJ,Stewart C,Ligon KL,Hoang MP,Van Hummelen P,Hahn WC,Louis DN,Resnick AC,Kieran MW,Getz G,Santagata S.Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.Nat Genet,2014,46(2):161–165.
[44]Li ML,Zhang Z,Li XG,Ye JY,Wu XS,Tan ZJ,Liu C,Shen BY,Wang XA,Wu WG,Zhou DZ,Zhang D,Wang T,Liu BY,Qu K,Ding QC,Weng H,Ding Q,Mu JS,Shu YJ,Bao RF,Cao Y,Chen PZ,Liu TY,Jiang L,Hu YP,Dong P,Gu J,Lu W,Shi WB,Lu JH,Gong W,Tang ZH,Zhang Y,Wang XF,Chin YE,Weng XL,Zhang H,Tang W,Zheng YL,He L,Wang H,Liu Y,Liu YB.Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the Erb B pathway.Nat Genet,2014,46(8):872–876.
[45]Kakiuchi M,Nishizawa T,Ueda H,Gotoh K,Tanaka A,Hayashi A,Yamamoto S,Tatsuno K,Katoh H,Watanabe Y,Ichimura T,Ushiku T,Funahashi S,Tateishi K,Wada I,Shimizu N,Nomura S,Koike K,Seto Y,Fukayama M,Aburatani H,Ishikawa S.Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.Nat Genet,2014,46(6):583–587.
[46]Xu B,Roos JL,Dexheimer P,Boone B,Plummer B,Levy S,Gogos JA,Karayiorgou M.Exome sequencing supports a de novo mutational paradigm for schizophrenia.Nat Genet,2011,43(9):864–868.
[47]Xu B,Roos JL,Levy S,van Rensburg EJ,Gogos JA,Karayiorgou M.Strong association of de novo copy number mutations with sporadic schizophrenia.Nat Genet,2008,40(7):880–885.
[48]Takata A,Xu B,Ionita-Laza I,Roos JL,Gogos JA,Karayiorgou M.Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene.Neuron,2014,82(4):773–780.
[49]Gregor A,Oti M,Kouwenhoven EN,Hoyer J,Sticht H,Ekici AB,Kjaergaard S,Rauch A,Stunnenberg HG,Uebe S,Vasileiou G,Reis A,Zhou HQ,Zweier C.De novo mutations in the genome organizer CTCF cause intellectual disability.Am J Hum Genet,2013,93(1):124–131.
[50]Tavassoli T,Kolevzon A,Wang AT,Curchack-Lichtin J,Halpern D,Schwartz L,Soffes S,Bush L,Grodberg D,Cai G,Buxbaum JD.De novo SCN2A splice site mutation in a boy with Autism spectrum disorder.BMC Med Genet,2014,15:35.
[51]Schaffer AE,Eggens VR,Caglayan AO,Reuter MS,Scott E,Coufal NG,Silhavy JL,Xue YC,Kayserili H,Yasuno K,Rosti RO,Abdellateef M,Caglar C,Kasher PR,Cazemier JL,Weterman MA,Cantagrel V,Cai N,Zweier C,Altunoglu U,Satkin NB,Aktar F,Tuysuz B,Yalcinkaya C,Caksen H,Bilguvar K,Fu XD,Trotta CR,Gabriel S,Reis A,Gunel M,Baas F,Gleeson JG.CLP1 founder mutation links t RNA splicing and maturation to cerebellar development and neurodegeneration.Cell,2014,157(3):651–663.
[52]Karaca E,Weitzer S,Pehlivan D,Shiraishi H,Gogakos T,Hanada T,Jhangiani SN,Wiszniewski W,Withers M,Campbell IM,Erdin S,Isikay S,Franco LM,Gonzaga-Jauregui C,Gambin T,Gelowani V,Hunter JV,Yesil G,Koparir E,Yilmaz S,Brown M,Briskin D,Hafner M,Morozov P,Farazi TA,Bernreuther C,Glatzel M,Trattnig S,Friske J,Kronnerwetter C,Bainbridge MN,Gezdirici A,Seven M,Muzny DM,Boerwinkle E,Ozen M,Clausen T,Tuschl T,Yuksel A,Hess A,Gibbs RA,Martinez J,Penninger JM,Lupski JR.Human CLP1 mutations alter t RNA biogenesis,affecting both peripheral and central nervous system function.Cell,2014,157(3):636–650.
[53]Glessner J,Bick AG,Ito K,Homsy J,Rodriguez-Murillo L,Fromer M,Mazaika EJ,Vardarajan B,Italia MJ,Leipzig J,De Palma S,Golhar R,Sanders SJ,Yamrom B,Ronemus M,Iossifov I,Willsey AJ,State MW,Kaltman JR,White PS,Shen Y,Warburton D,Brueckner M,Seidman C,Goldmuntz E,Gelb BD,Lifton R,Seidman JG,Hakonarson H,Chung WK.Increased frequency of de novo copy number variations in congenital heart disease by integrative analysis of SNP array and exome sequence data.Circ Res,2014:CIRCRESAHA.114.304458.
[54]Theis JL,Sharpe KM,Matsumoto ME,Chai HS,Nair AA,Theis JD,de Andrade M,Wieben ED,Michels VV,Olson TM.Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy.Circ Cardiovasc Genet,2011,4(6):585–594.
[55]Musunuru K,Pirruccello JP,Do R,Peloso GM,Guiducci C,Sougnez C,Garimella KV,Fisher S,Abreu J,Barry AJ,Fennell T,Banks E,Ambrogio L,Cibulskis K,Kernytsky A,Gonzalez E,Rudzicz N,Engert JC,De Pristo MA,Daly MJ,Cohen JC,Hobbs HH,Altshuler D,Schonfeld G,Gabriel SB,Yue P,Kathiresan S.Exome sequencing,ANGPTL3 mutations,and familial combined hypolipidemia.N Engl J Med,2010,363(23):2220–2227.
[56]Rios J,Stein E,Shendure J,Hobbs HH,Cohen JC.Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia.Hum Mol Genet,2010,19(22):4313–4318.
[57]Lange LA,Hu YN,Zhang H,Xue CY,Schmidt EM,Tang ZZ,Bizon C,Lange EM,Smith JD,Turner EH,Jun G,Kang HM,Peloso G,Auer P,Li KP,Flannick J,Zhang J,Fuchsberger C,Gaulton K,Lindgren C,Locke A,Manning A,Sim XL,Rivas MA,Holmen OL,Gottesman O,Lu YC,Ruderfer D,Stahl EA,Duan Q,Li Y,Durda P,Jiao S,Isaacs A,Hofman A,Bis JC,Correa A,Griswold ME,Jakobsdottir J,Smith AV,Schreiner PJ,Feitosa MF,Zhang Q,Huffman JE,Crosby J,Wassel CL,Do R,Franceschini N,Martin LW,Robinson JG,Assimes TL,Crosslin DR,Rosenthal EA,Tsai M,Rieder MJ,Farlow DN,Folsom AR,Lumley T,Fox ER,Carlson CS,Peters U,Jackson RD,van Duijn CM,Uitterlinden AG,Levy D,Rotter JI,Taylor HA,Gudnason VJ,Siscovick DS,Fornage M,Borecki IB,Hayward C,Rudan I,Chen YE,Bottinger EP,Loos RJ,Saetrom P,Hveem K,Boehnke M,Groop L,Mc Carthy M,Meitinger T,Ballantyne CM,Gabriel SB,O'Donnell CJ,Post WS,North KE,Reiner AP,Boerwinkle E,Psaty BM,Altshuler D,Kathiresan S,Lin DY,Jarvik GP,Cupples LA,Kooperberg C,Wilson JG,Nickerson DA,Abecasis GR,Rich SS,Tracy RP,Willer CJ.Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.Am J Hum Genet,2014,94(2):233–245.
[58]Kim DS,Crosslin DR,Auer PL,Suzuki SM,Marsillach J,Burt AA,Gordon AS,Meschia JF,Nalls MA,Worrall BB,Longstreth WJ Jr,Gottesman RF,Furlong CE,Peters U,Rich SS,Nickerson DA,Jarvik GP.Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project[S].J Lipid Res,2014,55(6):1173–1178.
[59]Yang YP,Muzny DM,Reid JG,Bainbridge MN,Willis A,Ward PA,Braxton A,Beuten J,Xia F,Niu ZY,Hardison M,Person R,Bekheirnia MR,Leduc MS,Kirby A,Pham P,Scull J,Wang M,Ding Y,Plon SE,Lupski JR,Beaudet AL,Gibbs RA,Eng CM.Clinical whole-exome sequencing for the diagnosis of mendelian disorders.N Engl J Med,2013,369(16):1502–1511.
[60]Mac Arthur DG,Manolio TA,Dimmock DP,Rehm HL,Shendure J,Abecasis GR,Adams DR,Altman RB,Antonarakis SE,Ashley EA,Barrett JC,Biesecker LG,Conrad DF,Cooper GM,Cox NJ,Daly MJ,Gerstein MB,Goldstein DB,Hirschhorn JN,Leal SM,Pennacchio LA,Stamatoyannopoulos JA,Sunyaev SR,Valle D,Voight BF,Winckler W,Gunter C.Guidelines for investigating causality of sequence variants in human disease.Nature,2014,508(7497):469–476.
[61]Biesecker LG,Green RC.Diagnostic clinical genome and exome sequencing.N Engl J Med,2014,370(25):2418–2425.
[62]Stenson PD,Ball EV,Mort M,Phillips AD,Shiel JA,Thomas NS,Abeysinghe S,Krawczak M,Cooper DN.Human Gene Mutation Database(HGMD):2003 update.Hum Mutat,2003,21(6):577–581.
[63]Gilissen C,Hoischen A,Brunner HG,Veltman JA.Disease gene identification strategies for exome sequencing.Eur J Hum Genet,2012,20(5):490–497.
[64]Quail MA,Smith M,Coupland P,Otto TD,Harris SR,Connor TR,Bertoni A,Swerdlow HP,Gu Y.A tale of three next generation sequencing platforms:comparison of Ion Torrent,Pacific Biosciences and Illumina Mi Seq sequencers.BMC Genomics,2012,13:341.
[65]Hoischen A,Gilissen C,Arts P,Wieskamp N,van der Vliet W,Vermeer S,Steehouwer M,de Vries P,Meijer R,Seiqueros J,Knoers NVAM,Buckley MF,Scheffer H,Veltman JA.Massively parallel sequencing of ataxia genes after array-based enrichment.Hum Mutat,2010,31(4):494–499.
[66]Yang X,Chockalingam SP,Aluru S.A survey of error-correction methods for next-generation sequencing.Brief Bioinform,2013,14(1):56–66.
[67]Schmitt MW,Kennedy SR,Salk JJ,Fox EJ,Hiatt JB,Loeb LA.Detection of ultra-rare mutations by next-generation sequencing.Proc Natl Acad Sci U S A,2012,109(36):14508–14513.
[68]Quail MA,Smith M,Coupland P,Otto TD,Harris SR,Connor TR,Bertoni A,Swerdlow HP,Gu Y.A tale of three next generation sequencing platforms:comparison of Ion Torrent,Pacific Biosciences and Illumina Mi Seq sequencers.BMC Genomics,2012,13:341.
[69]Robasky K,Lewis NE,Church GM.The role of replicates for error mitigation in next-generation sequencing.Nat Rev Genet,2014,15(1):56–62.
[70]张鑫,李敏,张学军.全基因组外显子测序及其应用.遗传,2011,33(8):847–856.